ARDSLEY ADVISORY PARTNERS LP Q1 2019 Filing

Filed May 15, 2019

Portfolio Value

$521.2M

Holdings

124

Report Date

Q1 2019

Filing Type

13F-HR

All Holdings (124 positions)

#StockSharesValue% PortfolioType
101
NUVECTRA CORP
25,095$276K0.05%
102
AM6AMICUS THERAPEUTICS INC
20,000$272K0.05%
103
DDD3-D SYS CORP DEL
25,000$269K0.05%
104
BNFTEURBENEFITFOCUS INC
5,000$248K0.05%
105
BDQMALBIREO PHARMA INC
7,600$245K0.05%
106
VIAVVIAVI SOLUTIONS INC
19,500$241K0.05%
107
ADMAADMA BIOLOGICS INC
61,300$233K0.04%
108
ENPHENPHASE ENERGY INC
25,000$230K0.04%
109
AZURE PWR GLOBAL LTD
20,000$225K0.04%
110
ABEONA THERAPEUTICS INC
30,000$221K0.04%
111
PLANUSDANAPLAN INC
5,500$217K0.04%
112
VONAGE HLDGS CORP
20,000$201K0.04%
113
VOYAVOYA FINL INC
4,000$200K0.04%
114
APOLLO ENDOSURGERY INC
48,688$182K0.03%
115
GSMFERROGLOBE PLC
80,000$164K0.03%Call
116
CAPSTONE TURBINE CORP
150,000$135K0.03%
117
SEELOS THERAPEUTICS INC
40,000$134K0.03%
118
CSTMCONSTELLIUM NV
10,500$84K0.02%
119
NEPTUNE WELLNESS SOLUTIONS I
25,000$80K0.02%
120
BIOSCRIP INC
25,000$50K0.01%
121
ACTINIUM PHARMACEUTICALS INC
75,000$36K0.01%
122
CORREVIO PHARMA CORP
10,366$33K0.01%
123
VTGNUSDVISTAGEN THERAPEUTICS INC
25,000$32K0.01%
124
SESEN BIO INC
20,500$21K0.00%
PreviousPage 2 of 2